Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 269, pseudogene (RN7SL269P)

Target
RN7SL269P
Molecular classification
Pseudogene, Non-coding RNA
01

Overview

RNA, 7SL, cytoplasmic 269, pseudogene (RN7SL269P) is a pseudogene related to the 7SL RNA family[4][6]. The 7SL RNA itself is a key non-coding RNA component of the signal recognition particle (SRP), which is crucial for targeting newly synthesized proteins to the endoplasmic reticulum[5]. However, pseudogenes such as RN7SL269P are generally nonfunctional: they are genomic DNA segments with similarity to functional genes (in this case, 7SL RNA genes), but due to mutations, truncations, or lack of necessary regulatory elements, they do not produce functional products[6]. Pseudogenes can occasionally be transcribed into RNA, but this is usually without biological significance; their existence can complicate genetic studies and annotation[6]. There is no evidence that RN7SL269P functions as a therapeutic target, encodes a protein, or has disease association, biomarker value, or drug interactions. Its classification is strictly as a processed pseudogene of the 7SL RNA gene family[1][6][4].

Other names
RN7SL269PRNA, 7SL, Cytoplasmic 269, Pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 269, pseudogene (RN7SL269P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 269, pseudogene (RN7SL269P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call